Japan cell therapy transaction yields $3MM
Cytori Therapeutics announced a transaction to divest certain cell therapy assets to Seijirō Shirahama of Tokyo, Japan yielding $3MM in non-dilutive funding to the Company, before related transaction expenses. April 23, 2019